Parkside Financial Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$394K Hold
884
0.04% 288
2025
Q1
$429K Buy
884
+17
+2% +$8.24K 0.05% 240
2024
Q4
$349K Sell
867
-40
-4% -$16.1K 0.05% 261
2024
Q3
$422K Buy
907
+8
+0.9% +$3.72K 0.06% 225
2024
Q2
$421K Buy
899
+16
+2% +$7.5K 0.07% 215
2024
Q1
$369K Buy
883
+76
+9% +$31.8K 0.06% 238
2023
Q4
$328K Buy
807
+162
+25% +$65.9K 0.06% 238
2023
Q3
$224K Buy
645
+50
+8% +$17.4K 0.05% 242
2023
Q2
$209K Buy
595
+134
+29% +$47.2K 0.05% 252
2023
Q1
$145K Buy
461
+33
+8% +$10.4K 0.04% 296
2022
Q4
$124K Buy
428
+13
+3% +$3.75K 0.04% 326
2022
Q3
$120K Buy
415
+7
+2% +$2.02K 0.04% 298
2022
Q2
$115K Buy
408
+26
+7% +$7.33K 0.04% 304
2022
Q1
$99K Buy
382
+30
+9% +$7.78K 0.03% 365
2021
Q4
$77K Buy
352
+28
+9% +$6.13K 0.02% 418
2021
Q3
$58K Buy
324
+7
+2% +$1.25K 0.02% 466
2021
Q2
$64K Buy
317
+21
+7% +$4.24K 0.02% 442
2021
Q1
$63K Sell
296
-9
-3% -$1.92K 0.02% 420
2020
Q4
$72K Sell
305
-19
-6% -$4.49K 0.02% 369
2020
Q3
$88K Sell
324
-3
-0.9% -$815 0.03% 316
2020
Q2
$95K Sell
327
-50
-13% -$14.5K 0.03% 314
2020
Q1
$90K Buy
377
+26
+7% +$6.21K 0.03% 275
2019
Q4
$77K Buy
351
+33
+10% +$7.24K 0.02% 343
2019
Q3
$54K Buy
318
+9
+3% +$1.53K 0.02% 397
2019
Q2
$57K Buy
309
+11
+4% +$2.03K 0.02% 375
2019
Q1
$55K Sell
298
-25
-8% -$4.61K 0.02% 365
2018
Q4
$54K Buy
323
+48
+17% +$8.03K 0.02% 341
2018
Q3
$53K Hold
275
0.02% 357
2018
Q2
$47K Sell
275
-81
-23% -$13.8K 0.02% 371
2018
Q1
$58K Buy
356
+7
+2% +$1.14K 0.02% 318
2017
Q4
$52K Sell
349
-11
-3% -$1.64K 0.02% 353
2017
Q3
$55K Buy
360
+34
+10% +$5.19K 0.02% 327
2017
Q2
$42K Buy
326
+126
+63% +$16.2K 0.02% 372
2017
Q1
$22K Buy
200
+10
+5% +$1.1K 0.01% 511
2016
Q4
$14K Sell
190
-14
-7% -$1.03K 0.01% 618
2016
Q3
$18K Buy
204
+8
+4% +$706 0.01% 593
2016
Q2
$17K Sell
196
-60
-23% -$5.2K 0.01% 580
2016
Q1
$20K Buy
256
+19
+8% +$1.48K 0.01% 523
2015
Q4
$30K Sell
237
-63
-21% -$7.98K 0.01% 428
2015
Q3
$31K Buy
+300
New +$31K 0.02% 392